UnknownNot Applicable

BroadBand Light for the Treatment of Dry Eye Disease

60 participantsStarted 2024-02-01

Plain-language summary

The investigators will be evaluating the use of broadband light in Dry Eye and Meibomian Gland Dysfunction.

Who can participate

Age range

18 Years – 100 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Fitzpatrick Skin Type I-V * Must be diagnosed with Dry eye disease (DED) and meibomian gland dysfunction (MGD) * Persistent dry eye signs and or symptoms after at least one prior DED treatment modality Exclusion Criteria: * Prior Intense pulsed light treatment for DED within the past six months * Prior Meibomian gland treatment with a device for DED within the past three months * History of trauma-induced ocular surface disease (thermal burns, chemical burns) * Subject is pregnant * History of seizures * Having significant unprotected sun exposure within the treatment area * Use of Accutane within the last six months * Use of doxycycline in the last 1 month * Allergy to proparacaine or lidocaine * Having active herpes simplex virus infection within the treatment area * Laser eye surgery (LASIK) within the past twelve months * History of abnormal response to sunlight * Having an active medical condition that may affect normal healing * Having active infections or compromised immune system * History of basal cell carcinoma in the treatment area within the past twelve months * History of keloid scar formation

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in dry eye score

Timeframe: 1 month after last BBL treatment (4 month time-point)

Trial details

NCT IDNCT06174064

SponsorUniversity of Southern California

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-01

Contact for this trial

Sandy Zhang-Nunes, MD

323-442-6335 sandy.zhang-nunes@med.usc.edu

View on ClinicalTrials.gov More Dry Eye Syndromes trials

Who can participate

Age range

18 Years – 100 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.